Welcome, Guest. Please login or register.

Author Topic: AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes  (Read 515 times)

0 Members and 1 Guest are viewing this topic.

The Web Team

  • Hero Member
  • *****
  • Posts: 8755
  • Karma: 14
    • View Profile
    • Qwoter
AtheroGenics Reports Positive Results From ANDES Phase 3 Clinical Trial of AGI-1067 in Type 2 Diabetes
           


<p>Company to Host Conference Call and Webcast on July 31, 2008 at 9 a.m. EDT</p>
           

http://www.marketwire.com/mw/release.do?id=884633&sourceType=3
           
The Web Team
Qwoter.com

Tags:
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
596 Views
Last post October 23, 2007, 09:00:33 PM
by The Web Team
0 Replies
464 Views
Last post February 01, 2008, 10:01:05 PM
by The Web Team
0 Replies
523 Views
Last post February 07, 2008, 08:00:51 PM
by The Web Team
0 Replies
534 Views
Last post February 26, 2008, 10:00:55 PM
by The Web Team
0 Replies
549 Views
Last post April 14, 2008, 06:00:35 PM
by The Web Team
0 Replies
630 Views
Last post May 13, 2008, 10:52:15 PM
by The Web Team
0 Replies
572 Views
Last post July 09, 2008, 03:08:38 AM
by The Web Team
0 Replies
622 Views
Last post July 15, 2008, 03:10:46 AM
by The Web Team
0 Replies
484 Views
Last post February 09, 2009, 02:01:24 PM
by Stock Spam
0 Replies
379 Views
Last post May 24, 2010, 01:33:50 PM
by manishds